Sulforaphane prevents diabetes-induced hepatic ferroptosis by activating Nrf2 signaling axis.
Level 5 - mechanism / opinion, no new human data
Preclinical animal laboratory study
PubMed 38299761 · doi:10.1002/biof.2042
What was done
Male C57BL/6 mice were allocated to four experimental groups: vehicle-treated control, streptozotocin-induced diabetic (40 mg/kg, days 1–5), diabetic treated with sulforaphane (2.5 mg/kg, days 1–42), and non-diabetic treated with sulforaphane (2.5 mg/kg, days 1–42). The authors measured markers of Nrf2 pathway activation, antioxidant defense enzymes, iron metabolism proteins (FTH1, ferroportin 1), glutathione synthesis and recycling pathways, ferritinophagy, labile iron, lipid peroxidation products (4-HNE, lipofuscin), liver damage indices (ALT, AST, fibrosis), and serum glucose and triglycerides.
What was found
The abstract reports directional effects without providing numerical values or effect sizes. Sulforaphane treatment in diabetic mice reversed Nrf2 inactivation and upregulated downstream antioxidant, iron-handling, and glutathione-related enzymes. Sulforaphane also increased glutathione levels, reduced ferritinophagy, decreased labile iron accumulation and lipid peroxides, lowered ALT and AST, reduced liver fibrosis, and significantly decreased serum glucose and triglyceride levels compared to untreated diabetic mice.
Why it matters
This study provides in vivo mechanistic evidence that sulforaphane counteracts diabetes-associated hepatic ferroptosis and oxidative stress through activation of the Nrf2 pathway.
Limits
The study was conducted entirely in a single chemically induced (streptozotocin) mouse model of diabetes, with no human data. Specific sample sizes per group, quantitative measurements, and variance estimates were omitted from the abstract. Findings cannot be directly translated to clinical outcomes or human dosing.
Cited by
- supports Sulforaphane upregulates enzymes responsible for synthesizing and resynthesizing glutathione, increasing available reduced glutathione.